Sep 16 2025
Topics Outside of Boston Hokkaido University to Participate in BIO Japan 2025
Topics Outside of Boston
Hokkaido University to Participate in BIO Japan 2025
In addition to our activities in Boston, we are also strengthening technology transfer activities in our home base. If you have the opportunity to visit Japan, please check BioJapan2025. It will be held at Pacifico Yokohama from Wednesday, October 8 to Friday, October 10, 2025. This event is one of the largest bio-business partnering exhibitions in Asia, bringing together exhibitions, seminars, and partnering in an integrated format, with the aim of promoting collaboration, joint research, and technology transfer among industry, academia, and government.
■URL
Researchers at Hokkaido University have been developing original and practical assets in a wide range of fields including drug discovery, diagnostic technologies, regenerative medicine, and biomaterials. At the venue, we are pleased to share the details about these programs and to explore opportunities for joint research and technology transfer. If you are interested in any of the assets listed in our portfolio, feel free to reach out to us via the BIO partnering system.
We look forward to connecting with you!
Assets Hokkaido University(Bio Japan 2025)
- Neurology & Rare Diseases
1: Therapeutic Protein for Promotion of Axon Regeneration in PNS and CNS
2: A new therapeutic peptides for Alzheimer’s disease
3: Novel suppressors of TDP aggregation for the therapeutic implication of ALS and FTLD
4: A neutrophil NETs inhibitor for axon regeneration
11: Programmable “srRNA” therapeutics to induce skipping of target exons – Alternatives to splicing regulatory antisense oligonucleotides
12: Gene therapy for mitochondrial diseases using genome editing technology
- Oncology & Immunology
13: Pancreatic cancer treatment drugs
14: Intracellular delivery of anti-interleukin-6 and anti-interleukin-6 receptor antibodies and inhibition of cancer cell growth using PIECE
15: A novel monoclonal antibody for Adult T-Cell Leukemia and Burkitt lymphoma
16: Treatment resistance reducing agent for treatment-resistant cancer
17: Hydrophilic-hydrophobic copolymers carrying Dichloroacetic acid on side chain and medical use therof
18: Pancreatic cancer therapeutic peptide
19: Novel STING Agonist
20: STAP-1 Therapeutic Peptide for Autoimmune disease
21: Meflin is involved in the development of inflammatory diseases as a novel TNF receptor ligand
- Infectious & Immune-related Diseases
22: Amelioration of liver fibrosis with autologous macrophages induced by IL-34-based condition
23: Novel Resolvin E3 derivatives or pharmaceutical composition containing the same
24: A repurposing drug candidate that can suppress rebound bone resorption after administration of anti-RANKL antibody, a treatment for osteoporosis
27: Novel Antibodies for Marburg Virus Therapy
28: A Highly Cross-Neutralizing Antibody for Ebolavirus Therapy
29: Novel antibacterial peptides
- Organ-specific & Clinical Applications
25: Novel peptides for glaucoma treatment
26: Anti-photoaging topical agent that can be a repurposing drug candidate for skin aging diseases including xeroderma pigmentosum and skin cancer by removing senescent cells
33: Imaging Diagnosis of Hip Joint Disorders
43: Interstitial pneumonia treatment equipment
44: Automatic detection of arteriovenous crossover phenomena in fundus photographs using line thinning and pixel tone analysis technology
45: Fiber Structure Inducing Member and Method for Producing the Inducing Member
- Drug Delivery & Enabling Technologies
5: A Novel Lipid for Hepatic stellate cells (HSC)
6: Optimized LNP for the spleen delivery
7: Novel Helper Lipids that accelerate endosomal escapes
8: Lipid nanoparticles for ribonucleoprotein delivery for in vivo genome editing
9: Novel Delivery programs for NK cells for cancer treatment
10: Nucleic acid complex composition, lipid particles for transfection, and transfection method
30: Development of blood fibrosis markers for nonalcoholic steatohepatitis
31: Methods and kits for detecting human α-defensin HD5 and antibodies used in said methods and kits
34: Comprehensive detection method for parasites using portable NGS
35: Short-wave infrared (SWIR) fluorescent agents and non-invasive in vivo optical imaging methods
36: Shortwave infrared fluorescent dyes for highly sensitive detection of tumors via EPR effect
37: Novel mammalian cell expression vectors capable of producing high levels of exogenous proteins
38: Widely applicable as a general strategy for the optimization of peptide sequences
39: New macrocyclic peptide library and Peptide Engineering Technologies
- Research Tools & Experimental Models
32: Method for detecting autoantigens of immune-mediated disease, and kit for detecting autoantigens of immune-mediated disease
40: Photoswitchable Auxin-Inducible Degron System for Conditional Protein Degradation with Spatiotemporal Resolution
41: Exosome-like particles and virus-like particles
42: Method for Temporal Evaluation of Reproductive Toxicity Using Bioluminescent Imaging and Genetically Modified Mice
